Reading Room Production — page 144

ol ol a 5 AM AID DEA DART NIAID) [E] 7 NIAID) [E] \IH/NIAID) [E] ii NIH/NIAID) [E] J VIH/NIAID) [I] iy >; I I (NIH/NIAID) [E] NIH/NIAID) [E] ay NIAID) [E] In the attached revised draft, I jections, I will submit these to NIH tt iy PM [AID DEA DART NIAID) (E] i I NIAID) [E] \IH/NIAID) [E] ii NIH/NIAID) [E] J VIH/NIAID) [Ee] >; I I (NIH/NIAID) [E] NIH/NIAID) [E] ay NIAID) [E] has asked us to ze Sara From: Selgrade, Sara (NIH/NIAID) [E] @nih.gov> Sent: Monday, July 15, 2024 10:35 AM To: NIAID BUGS @niaid.nih.gov>; NIAID DEA DART @mail.nih.gov>; NIAID DIR-OCGR <NIAIDDIR- @mail.nih.gov>; Nealy, Michael (NIH/NIAID) [E] @nih.gov>; Auchincloss, Hugh (NIH/NIAID) [E] @niaid.nih.gov>; Harper, Jill (NIH/NIAID) [E] @niaid.nih.gov>; Parker, Marie (NIH/NIAID) [E] @niaid.nih.gov>; Billet, Courtney (NIH/NIAID) [E] @niaid.nih.gov> Cc: NIAID OCGR Leg @mail.nih.gov>; Erbelding, Emily (NIH/NIAID) [E] @nih.gov>; Holland, Steven (NIH/NIAID) [E] @niaid.nih.gov>; Hanson, Christopher (NIH/NIAID) [E] @niaid.nih.gov>; Poe, Kelly (NIH/NIAID) [E] @nih.gov>; Gilles, Sharon (NIH/NIAID) [E] @nih.gov>; DDSM Correspondences @mail.nih.gov> Subject: For review by noon Monday 7/15: Review draft NIAID TA on Risky Research Review Act Importance: High Hello all, Thank you for your quick review of the draft NIAID TA on the Risky Research Review Act. In the attached revised draft, I have incorporated additional edits from DMID/Dr. Erbelding and DEA. If there are no objections, I will submit these to NIH OLPA by their noon deadline today. I am also attaching for your reference additional comments on the bill provided by NIH OER and NIH ORS/DOHS. Please let me know if you have any questions or concerns. Thanks, Sara From: Selgrade, Sara (NIH/NIAID) [E] @nih.gov> Sent: Friday, July 12, 2024 4:06 PM To: NIAID BUGS @niaid.nih.gov>; NIAID DEA DART @mail.nih.gov>; NIAID DIR-OCGR <NIAIDDIR- @mail.nih.gov>; Nealy, Michael (NIH/NIAID) [E] @nih.gov>; Auchincloss, Hugh (NIH/NIAID) [E] @niaid.nih.gov>; Harper, Jill (NIH/NIAID) [E] @niaid.nih.gov>; Parker, Marie (NIH/NIAID) [E] @niaid.nih.gov>; Billet, Courtney (NIH/NIAID) [E] @niaid.nih.gov> Cc: NIAID OCGR Leg @mail.nih.gov>; Erbelding, Emily (NIH/NIAID) [E] @nih.gov>; Holland, Steven (NIH/NIAID) [E] @niaid.nih.gov>; Hanson, Christopher (NIH/NIAID) [E] @niaid.nih.gov>; Poe, Kelly (NIH/NIAID) [E] @nih.gov>; Gilles, Sharon (NIH/NIAID) [E] @nih.gov>; DDSM Correspondences @mail.nih.gov> Subject: URGENT ACTION by 10am Monday 7/15: Review draft NIAID TA on Risky Research Review Act Importance: High Hello all, Background Thank you very much for your quick work to comment on the Risky Research Review Act. NIH OLPA has asked us to prioritize comments to flag the most urgent or concerning items and/or those needing clarification. Action Item We have compiled the comments that meet NIH OLPA's request into the attached draft technical assistance document. Please note that NIH OLPA has requested examples, where possible. We have tried to add some examples to emphasize key points, but we welcome any suggestions and/or corrections as needed.